
Bayer CropScience's recent performance positions it strongly within the market, reflected in its substantial stock price increase and enhanced financial metricsShares of Bayer CropScience rose by 13% on Tuesday, 27th May, following the release of the company's impressive fourth-quarter earnings. The company's net profit surged by 49.27% to ₹143 crore compared to ₹96 crore in the corresponding period last year. The earnings before interest, taxes, depreciation and amortisation (EBITDA) also saw a significant increase, marking a 75.4% rise to ₹170.8 crore from ₹97.4 crore in the prior year's fourth quarter. This performance has resulted in an expanded margin for Bayer CropScience, which increased to 16.3% from 12.3% reported in the same period last year.
The company reported a revenue of ₹1,046.4 crore, which represents a 32.1% increase from the previous year's ₹792.3 crore. This growth was largely driven by strong performance in the spring corn sector and double-digit growth in the crop protection portfolio. The strong financial results contributed to the stock reaching an intraday high of ₹5,802 and trading at ₹5,757, up 12.2% by 10:15 am. Over the past month, the stock has appreciated by 20%. Moreover, Bayer CropScience's board of directors has recommended a final dividend of ₹35 per share, pending approval from shareholders at the upcoming annual general meeting.